Utilization of biomarkers for the prognostic prediction of cardiac arrest survivors using a multi-modal approach.

International guidelines for post-cardiac arrest care recommend using multi-modal strategies to avoid the withdrawal of life-sustaining therapy(WLST)in patients with the potential for neurological recovery.[1]However,a clear methodology for multi-modal approaches has yet to be developed.Neuron-specific enolase(NSE)is currently the only recommended biomarker,and the European Resuscitation Council(ERC)and the European Society of Intensive Care Medicine(ESICM)have proposed a cutoff value of 60 µg/L at 48 and/or 72 h after the return of spontaneous circulation(ROSC)as a multi-modal prognostic tool for predicting poor neurological outcomes.